| Literature DB >> 25003052 |
Samer Hammoudeh1, Abdulbari Bener1, Mahmoud Zirie1, Abdullah Al-Hamaq1, Prem Chandra1, Olivia Moses1, Hildemar Dos Santos1, Serena Tonstad1.
Abstract
Metabolic syndrome is a cluster of metabolic abnormalities that increases the risk of cardiovascular disease and type 2 diabetes. Total human energy expenditure is divided into three major components; resting metabolic rate, thermic effect of food, and activity thermogenesis which is divided into exercise and non exercise activity thermogenesis (NEAT). In this study, NEAT was used as a lifestyle intervention on subjects with metabolic syndrome. 200 eligible patients from the Diabetes and Endocrinology Department at Hamad Medical Hospital in Doha, Qatar were assigned to an intervention (n = 100) or control (n = 100) group and followed for one year. The intervention group was advised to practice NEAT enhancing activities, while the control group was not advised about NEAT. Measurements of waist circumference, weight, BMI, blood pressure, glucose and lipid profile were assessed at baseline, six months and 1 year. After 1 year 52 intervention and 55 control subjects completed the study. The results revealed no statistically significant differences in metabolic syndrome components between the two randomized groups. The amount of recommended NEAT activity appears to have been too small to influence study outcomes. Future studies in similar populations may need to consider the high dropout rate, and use of incentives or other interventions to increase compliance and retention.Entities:
Year: 2013 PMID: 25003052 PMCID: PMC3991052 DOI: 10.5339/qmj.2013.3
Source DB: PubMed Journal: Qatar Med J ISSN: 0253-8253
Figure 1.Flow chart showing study progress.
Patient demographics, metabolic syndrome components, and anthropometrics (Quantitative values expressed as mean ± SD/ p value derived using independent t test, qualitative values expressed as number (percentage)/ p value derived using chi square test).
| Variable | Intervention | Control |
|
| Gender | (n = 100) | (n = 100) | |
|
| |||
| Male | 58 (58%) | 62 (62%) | 0.564 |
|
| |||
| Female | 42 (42%) | 38 (38%) | |
|
| |||
| Age (years) | (n = 100) | (n = 100) | |
|
| |||
| Mean ± SD | 57.1 ± 13.44 | 55.9 ± 12.32 | 0.490 |
|
| |||
| Median (Range) | 56.5 (20-84) | 57.5 (18-85) | |
|
| |||
| Marital Status | (n = 100) | (n = 100) | |
|
| |||
| Married | 83 (83.0%) | 88 (88.0%) | 0.195 |
|
| |||
| Single | 9 (9.0%) | 10 (10.0%) | |
|
| |||
| Widowed | 7 (7.0%) | 1 (1.0%) | |
|
| |||
| Divorced | 1 (1.0%) | 1 (1.0%) | |
|
| |||
| Height (cm) | (n = 100) | (n = 100) | |
|
| |||
| Mean ± SD | 162.7 ± 8.71 | 162.3 ± 9.29 | 0.772 |
|
| |||
| Median (Range) | 162.0 (139-182) | 161.0 (143-185) | |
|
| |||
| Weight (kg) | (n = 100) | (n = 100) | |
|
| |||
| Mean ± SD | 86.9 ± 18.48 | 87.0 ± 19.25 | 0.952 |
|
| |||
| BMI (kg/m2) | (n = 100) | (n = 100) | |
|
| |||
| Mean ± SD | 33.0 ± 7.04 | 33.1 ± 7.66 | 0.935 |
|
| |||
| Waist circumference (cm) | (n = 100) | (n = 100) | |
|
| |||
| Mean ± SD | 108.2 ± 12.26 | 108.4 ± 14.13 | 0.902 |
|
| |||
| Glucose (mmol/L) | (n = 94) | (n = 93) | |
|
| |||
| Mean ± SD | 8.4 ± 3.15 | 8.5 ± 3.5 | 0.762 |
|
| |||
| High-density lipoprotein cholesterol (mmol/L) | (n = 92) | (n = 94) | |
|
| |||
| Mean ± SD | 1.1 ± 0.28 | 1.1 ± 0.35 | 0.595 |
|
| |||
| Low-density lipoprotein cholesterol (mmol/L) | (n = 92) | (n = 94) | |
|
| |||
| Mean ± SD | 2.7 ± 0.94 | 2.7 ± 0.89 | 0.872 |
|
| |||
| Triglyceride (mmol/L) | (n = 92) | (n = 94) | |
|
| |||
| Mean ± SD | 1.6 ± 0.94 | 1.6 ± 1.1 | 0.970 |
|
| |||
| Cholesterol (mmol/L) | (n = 92) | (n = 93) | |
|
| |||
| Mean ± SD | 4.6 ± 1.1 | 4.6 ± 1.0 | 0.965 |
|
| |||
| Systolic blood pressure (mmHg) | (n = 100) | (n = 99) | |
|
| |||
| Mean ± SD | 145.1 ± 18.51 | 140.5 ± 20.18 | 0.096 |
|
| |||
| Diastolic blood pressure (mmHg) | (n = 100) | (n = 99) | |
|
| |||
| Mean ± SD | 76.8 ± 10.65 | 76.3 ± 10.77 | 0.744 |
|
| |||
| Medications | (n = 90) | (n = 88) | |
|
| |||
| Anti-diabetic | |||
|
| |||
| Yes | 65 (72.2%) | 64 (72.7%) | 0.940 |
|
| |||
| No | 25 (27.8%) | 24 (27.3%) | |
|
| |||
| Lipid-lowering | |||
|
| |||
| Yes | 62 (68.9%) | 62 (70.5%) | 0.820 |
|
| |||
| No | 28 (31.1%) | 26 (29.5%) | |
|
| |||
| Anti-hypertensive | |||
|
| |||
| Yes | 69 (76.7%) | 66 (75.0%) | 0.795 |
|
| |||
| No | 21 (23.3%) | 22 (25.0%) | |
Patients' metabolic syndrome components (p value derived using chi square test).
| Components of metabolic syndrome | Intervention | Control |
|
| Elevated waist circumference | (n = 100) | (n = 100) | |
|
| |||
| Yes | 95 (95.0%) | 92 (92.0%) | 0.390 |
|
| |||
| No | 5 (5.0%) | 8 (8.0%) | |
|
| |||
| Elevated triglycerides | (n = 94) | (n = 98) | |
|
| |||
| Yes | 63 (67.0%) | 63 (64.3%) | 0.690 |
|
| |||
| No | 31 (33.0%) | 35 (35.7%) | |
|
| |||
| Elevated blood pressure | (n = 100) | (n = 99) | |
|
| |||
| Yes | 91 (91.0%) | 88 (88.9%) | 0.620 |
|
| |||
| No | 9 (9.0%) | 11 (11.1%) | |
|
| |||
| Reduced HDL cholesterol | (n = 94) | (n = 96) | |
|
| |||
| Yes | 70 (74.5%) | 80 (83.3%) | 0.134 |
|
| |||
| No | 24 (25.5%) | 16 (16.7%) | |
|
| |||
| Elevated glucose | (n = 97) | (n = 96) | |
|
| |||
| Yes | 86 (88.7%) | 82 (85.4%) | 0.502 |
|
| |||
| No | 11 (11.3%) | 14 (14.6%) | |
Comparison of anthropometric and metabolic parameters at baseline, 6 months, and 12 months in completers in the intervention and control group (p value derived using repeated measures ANOVA test).
| Time Points | ||||
|
| ||||
| Baseline | 6 months | 12 months | ||
|
| ||||
| Variable | (Mean ± SD) | (Mean ± SD) | (Mean ± SD) |
|
| Weight (kg) | ||||
|
| ||||
| Intervention (n = 48) | 84.2 ± 18.51 | 84.6 ± 18.46 | 84.9 ± 19.16 | 0.677 |
|
| ||||
| Control (n = 49) | 86.5 ± 20.19 | 85.9 ± 20.34 | 86.3 ± 21.23 | |
|
| ||||
| Body mass index (kg/m2) | ||||
|
| ||||
| Intervention (n = 47) | 32.15 ± 7.62 | 32.26 ± 7.42 | 32.38 ± 7.74 | 0.611 |
|
| ||||
| Control (n = 49) | 33.21 ± 8.32 | 32.99 ± 8.37 | 33.12 ± 8.77 | |
|
| ||||
| Waist circumference (cm) | ||||
|
| ||||
| Intervention (n = 40) | 104.5 ± 13.21 | 104.6 ± 11.38 | 104.6 ± 11.44 | 0.159 |
|
| ||||
| Control (n = 47) | 108.5 ± 13.21 | 108.1 ± 13.24 | 108.4 ± 13.38 | |
|
| ||||
| Glucose (mmol/L) | ||||
|
| ||||
| Intervention (n = 45) | 8.78 ± 3.54 | 8.86 ± 3.83 | 8.62 ± 3.47 | 0.501 |
|
| ||||
| Control (n = 39) | 9.42 ± 3.93 | 9.29 ± 4.42 | 9.09 ± 4.33 | |
|
| ||||
| High-density lipoprotein cholesterol (mmol/L) | ||||
|
| ||||
| Intervention (n = 43) | 1.14 ± 0.29 | 1.10 ± 0.25 | 1.15 ± 0.28 | 0.396 |
|
| ||||
| Control (n = 38) | 1.05 ± 0.31 | 1.03 ± 0.28 | 1.15 ± 0.51 | |
|
| ||||
| Low-density lipoprotein cholesterol (mmol/L) | ||||
|
| ||||
| Intervention (n = 43) | 2.57 ± 0.81 | 2.63 ± 0.71 | 2.58 ± 0.68 | 0.789 |
|
| ||||
| Control (n = 39) | 2.53 ± 0.79 | 2.56 ± 0.70 | 2.58 ± 1.05 | |
|
| ||||
| Triglyceride (mmol/L) | ||||
|
| ||||
| Intervention (n = 43) | 1.64 ± 0.93 | 1.47 ± 0.68 | 1.51 ± 0.65 | 0.124 |
|
| ||||
| Control (n = 39) | 1.79 ± 1.45 | 2.02 ± 1.66 | 1.87 ± 1.35 | |
|
| ||||
| Cholesterol (mmol/L) | ||||
|
| ||||
| Intervention (n = 43) | 4.55 ± 0.90 | 4.40 ± 0.73 | 4.38 ± 0.82 | 0.889 |
|
| ||||
| Control (n = 39) | 4.41 ± 1.09 | 4.45 ± 0.82 | 4.54 ± 1.42 | |
|
| ||||
| Systolic blood pressure (mmHg) | ||||
|
| ||||
| Intervention (n = 43) | 144.77 ± 19.60 | 137.49 ± 18.76 | 137.21 ± 16.64 | 0.456 |
|
| ||||
| Control (n = 46) | 142.07 ± 19.94 | 143.59 ± 18.82 | 141.24 ± 19.19 | |
|
| ||||
| Diastolic blood pressure (mmHg) | ||||
|
| ||||
| Intervention (n = 43) | 75.79 ± 9.03 | 75.12 ± 9.39 | 72.72 ± 9.46 | 0.218 |
|
| ||||
| Control (n = 46) | 75.70 ± 11.76 | 78.22 ± 10.81 | 76.15 ± 10.43 | |
|
| ||||
| Number of components of metabolic syndrome | ||||
|
| ||||
| Intervention (n = 50) | 3.64 ± 0.77 | 3.68 ± 0.79 | 3.78 ± 0.76 | 0.059 |
|
| ||||
| Control (n = 45) | 3.98 ± 0.78 | 3.96 ± 0.85 | 4.02 ± 0.86 | |